Samuel Samnick
Department of Nuclear Medicine
Saarland University Medical Center
66421 Homburg/Saar
Germany
Name/email consistency: medium
- Preparation and tumor affinity testing of the radioiodinated tetrahydroisoquinoline derivative [123I]TIC(OH) for targeting prostate cancer. Samnick, S., Fozing, T., Kirsch, C.M. Appl. Radiat. Isot (2006)
- p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma. Samnick, S., Romeike, B.F., Kubuschok, B., Hellwig, D., Amon, M., Feiden, W., Menger, M.D., Kirsch, C.M. Eur. J. Nucl. Med. Mol. Imaging (2004)
- Technetium-99m labeled 1-(4-fluorobenzyl)-4-(2-mercapto-2-methyl-4-azapentyl)-4-(2-mercapto-2-methylpropylamino)-piperidine and iodine-123 metaiodobenzylguanidine for studying cardiac adrenergic function: a comparison of the uptake characteristics in vascular smooth muscle cells and neonatal cardiac myocytes, and an investigation in rats. Samnick, S., Scheuer, C., Münks, S., El-Gibaly, A.M., Menger, M.D., Kirsch, C.M. Nucl. Med. Biol. (2004)









